Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications

The development of novel anticancer agents is essential to finding new ways to treat this disease, one of the deadliest diseases. Some marine organisms have proved to be important producers of chemically active compounds with valuable bioactive properties, including anticancer. Thus, the ocean has p...

Full description

Bibliographic Details
Main Authors: Ana C. S. Veríssimo, Mário Pacheco, Artur M. S. Silva, Diana C. G. A. Pinto
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/14/4292
_version_ 1797526511155150848
author Ana C. S. Veríssimo
Mário Pacheco
Artur M. S. Silva
Diana C. G. A. Pinto
author_facet Ana C. S. Veríssimo
Mário Pacheco
Artur M. S. Silva
Diana C. G. A. Pinto
author_sort Ana C. S. Veríssimo
collection DOAJ
description The development of novel anticancer agents is essential to finding new ways to treat this disease, one of the deadliest diseases. Some marine organisms have proved to be important producers of chemically active compounds with valuable bioactive properties, including anticancer. Thus, the ocean has proved to be a huge source of bioactive compounds, making the discovery and study of these compounds a growing area. In the last few years, several compounds of marine origin, which include algae, corals, and sea urchins, have been isolated, studied, and demonstrated to possess anticancer properties. These compounds, mainly from securamines and sterols families, have been tested for cytotoxic/antiproliferative activity in different cell lines. Bioactive compounds isolated from marine organisms in the past 5 years that have shown anticancer activity, emphasizing the ones that showed the highest cytotoxic activity, such as securamines H and I, cholest-3β,5α,6β-triol, (<i>E</i>)-24-methylcholest-22-ene-3β,5α,6β-triol, 24-methylenecholesta-3β,5α,6β-triol, and 24-methylcholesta-3β,5α,6β-triol, will be discussed in this review. These studies reveal the possibility of new compounds of marine origin being used as new therapeutic agents or as a source of inspiration to develop new therapeutic agents.
first_indexed 2024-03-10T09:30:45Z
format Article
id doaj.art-a5c0541bb75848af86d2b545abdf8a3e
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T09:30:45Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-a5c0541bb75848af86d2b545abdf8a3e2023-11-22T04:31:33ZengMDPI AGMolecules1420-30492021-07-012614429210.3390/molecules26144292Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer ApplicationsAna C. S. Veríssimo0Mário Pacheco1Artur M. S. Silva2Diana C. G. A. Pinto3LAQV-REQUIMTE & Department of Chemistry, University of Aveiro, 3810-193 Aveiro, PortugalCESAM & Department of Biology, University of Aveiro, 3810-193 Aveiro, PortugalLAQV-REQUIMTE & Department of Chemistry, University of Aveiro, 3810-193 Aveiro, PortugalLAQV-REQUIMTE & Department of Chemistry, University of Aveiro, 3810-193 Aveiro, PortugalThe development of novel anticancer agents is essential to finding new ways to treat this disease, one of the deadliest diseases. Some marine organisms have proved to be important producers of chemically active compounds with valuable bioactive properties, including anticancer. Thus, the ocean has proved to be a huge source of bioactive compounds, making the discovery and study of these compounds a growing area. In the last few years, several compounds of marine origin, which include algae, corals, and sea urchins, have been isolated, studied, and demonstrated to possess anticancer properties. These compounds, mainly from securamines and sterols families, have been tested for cytotoxic/antiproliferative activity in different cell lines. Bioactive compounds isolated from marine organisms in the past 5 years that have shown anticancer activity, emphasizing the ones that showed the highest cytotoxic activity, such as securamines H and I, cholest-3β,5α,6β-triol, (<i>E</i>)-24-methylcholest-22-ene-3β,5α,6β-triol, 24-methylenecholesta-3β,5α,6β-triol, and 24-methylcholesta-3β,5α,6β-triol, will be discussed in this review. These studies reveal the possibility of new compounds of marine origin being used as new therapeutic agents or as a source of inspiration to develop new therapeutic agents.https://www.mdpi.com/1420-3049/26/14/4292secondary metabolitesmarine organismssecuraminessterolsanticancercytotoxic activity
spellingShingle Ana C. S. Veríssimo
Mário Pacheco
Artur M. S. Silva
Diana C. G. A. Pinto
Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
Molecules
secondary metabolites
marine organisms
securamines
sterols
anticancer
cytotoxic activity
title Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
title_full Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
title_fullStr Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
title_full_unstemmed Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
title_short Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
title_sort secondary metabolites from marine sources with potential use as leads for anticancer applications
topic secondary metabolites
marine organisms
securamines
sterols
anticancer
cytotoxic activity
url https://www.mdpi.com/1420-3049/26/14/4292
work_keys_str_mv AT anacsverissimo secondarymetabolitesfrommarinesourceswithpotentialuseasleadsforanticancerapplications
AT mariopacheco secondarymetabolitesfrommarinesourceswithpotentialuseasleadsforanticancerapplications
AT arturmssilva secondarymetabolitesfrommarinesourceswithpotentialuseasleadsforanticancerapplications
AT dianacgapinto secondarymetabolitesfrommarinesourceswithpotentialuseasleadsforanticancerapplications